Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials

DOI10.12688/f1000research.10624.3MaRDI QIDQ60287

David C. Norris

Publication date: 17 July 2017

Published in: F1000Research (Search for Journal in Brave)

Related Items

DTAT